Molecular Basis of Triple Negative Breast Cancer and Implications for Therapy

@inproceedings{Peddi2012MolecularBO,
  title={Molecular Basis of Triple Negative Breast Cancer and Implications for Therapy},
  author={Parvin F. Peddi and Matthew J. Ellis and Cynthia X. Ma},
  booktitle={International journal of breast cancer},
  year={2012}
}
Triple negative breast cancer is an aggressive form of breast cancer with limited treatment options and is without proven targeted therapy. Understanding the molecular basis of triple negative breast cancer is crucial for effective new drug development. Recent genomewide gene expression and DNA sequencing studies indicate that this cancer type is composed of a molecularly heterogeneous group of diseases that carry multiple somatic mutations and genomic structural changes. These findings have… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 44 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 66 references

Epigenetic portraits of human breast cancers

  • D. Sharma, B. B. Knight, R. Yacoub, T. Liu, A. Taliaferro-Smith
  • Annals of Oncology
  • 2011

Identification of human triplenegative breast cancer subtypes and preclinical models for selection of targeted therapies

  • Z. Szallasi, A. C. Eklund
  • The Journal of Clinical Investigation
  • 2011

Phase II Trial of Saracatinib ( AZD 0530 ) , an Oral SRCinhibitor for the Treatment of Patients with Hormone Receptornegative Metastatic Breast Cancer

  • S. Dedeurwaerder, C. Desmedt, E. Calonne, S. K. Singhal, B. Haibe-Kains
  • Clinical Breast Cancer
  • 2011

R

  • A. I. Phipps, R. T. Chlebowski
  • Prentice et al., “Body size, physical activity…
  • 2011

S

  • A. M. Gonzalez-Angulo, K. M. Timms
  • Liu et al., “Incidence and outcome of BRCA…
  • 2011

Similar Papers

Loading similar papers…